DE SANTIS, SARA
 Distribuzione geografica
Continente #
AS - Asia 1.677
NA - Nord America 956
EU - Europa 691
AF - Africa 88
SA - Sud America 76
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 3
Totale 3.550
Nazione #
US - Stati Uniti d'America 913
VN - Vietnam 740
SG - Singapore 378
IT - Italia 289
CN - Cina 249
HK - Hong Kong 110
DE - Germania 79
NL - Olanda 63
GB - Regno Unito 55
BR - Brasile 54
SE - Svezia 49
IN - India 36
IE - Irlanda 35
FR - Francia 34
KR - Corea 33
TG - Togo 29
BD - Bangladesh 24
CA - Canada 22
CI - Costa d'Avorio 22
RU - Federazione Russa 19
FI - Finlandia 17
ZA - Sudafrica 16
JO - Giordania 12
JP - Giappone 12
TW - Taiwan 12
IQ - Iraq 11
IR - Iran 11
NG - Nigeria 11
PL - Polonia 10
TH - Thailandia 10
AT - Austria 8
EC - Ecuador 6
ES - Italia 6
PH - Filippine 6
AR - Argentina 5
CH - Svizzera 5
CR - Costa Rica 5
ID - Indonesia 5
MX - Messico 5
SC - Seychelles 5
UA - Ucraina 5
BG - Bulgaria 4
JM - Giamaica 4
MY - Malesia 4
SA - Arabia Saudita 4
AU - Australia 3
LT - Lituania 3
PK - Pakistan 3
TR - Turchia 3
UY - Uruguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
MA - Marocco 2
PS - Palestinian Territory 2
SV - El Salvador 2
AM - Armenia 1
AZ - Azerbaigian 1
BZ - Belize 1
CO - Colombia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
MM - Myanmar 1
NI - Nicaragua 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 3.492
Città #
Singapore 296
Ho Chi Minh City 242
Hanoi 185
Ashburn 104
Hong Kong 103
Chandler 100
San Jose 91
Bologna 67
Hefei 60
Southend 40
Dublin 35
Beijing 30
Lomé 29
Santa Clara 29
Seoul 29
Council Bluffs 26
Boardman 25
Milan 24
Abidjan 22
Da Nang 20
Fairfield 20
Haiphong 20
Princeton 20
Redmond 20
Frankfurt am Main 19
Ha Long 19
Rome 18
New York 15
Biên Hòa 14
Lauterbourg 13
Los Angeles 13
Thái Nguyên 13
Houston 12
Redondo Beach 12
Wilmington 12
Johannesburg 11
Tokyo 11
Abeokuta 10
Berlin 10
Woodbridge 10
Montreal 9
Tehran 9
Turin 9
Amman 8
Atlanta 8
Buffalo 8
Chicago 8
Dallas 8
Hải Dương 8
Seattle 8
Vũng Tàu 8
Bengaluru 7
Bắc Ninh 7
Cambridge 7
Guangzhou 7
Munich 7
Nuremberg 7
Quận Bình Thạnh 7
Shanghai 7
São Paulo 7
Warsaw 7
Zhengzhou 7
Điện Bàn 7
Florence 6
Helsinki 6
Lappeenranta 6
London 6
Ninh Bình 6
San Diego 6
Vinh 6
Bangkok 5
Bern 5
Boydton 5
Brescia 5
Falkenstein 5
Huế 5
Phoenix 5
Quận Hai 5
Quận Phú Nhuận 5
Quận Sáu 5
San José 5
Thái Bình 5
Tianjin 5
Turku 5
Ann Arbor 4
Baghdad 4
Boston 4
Brooklyn 4
Bến Tre 4
Can Tho 4
Catania 4
Dehradun 4
Des Moines 4
Lang Son 4
Medford 4
Nha Trang 4
Quảng Ngãi 4
Quận Năm 4
Shenyang 4
Sofia 4
Totale 2.200
Nome #
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 675
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 302
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors 234
The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities 182
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells 179
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 173
Polo-like Kinase-1 and Aurora Kinase A As Novel Therapeutic Targets in Neoplastic Mast Cells 173
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis 171
Recent advances in the molecular biology of systemic mastocytosis: Implications for diagnosis, prognosis, and therapy 167
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia 166
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors 161
SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications 161
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights 148
Targeting leukemic stem cells in chronic myeloid leukemia: Is it worth the effort? 140
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis 127
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia 117
CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors 116
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability 87
Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia 71
Totale 3.550
Categoria #
all - tutte 9.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022169 0 0 5 4 20 12 2 15 11 15 50 35
2022/2023376 42 62 9 31 39 21 19 15 71 13 42 12
2023/2024132 1 25 13 20 12 13 5 17 3 9 11 3
2024/2025637 23 112 57 47 35 24 68 30 20 65 62 94
2025/20261.952 192 563 102 132 140 57 123 43 350 99 99 52
2026/2027137 31 40 66 0 0 0 0 0 0 0 0 0
Totale 3.550